SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing session: reset
Follow Your Heart: Managing Cardiovascular Disease Risk in HIV
- Sort by:
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
5 of
5
|
Overview of the REPRIEVE Trial
Steven K. Grinspoon
Massachusetts General Hospital, Boston, MA, USA
Sex Differences in Atherosclerotic CVD Risks and Mechanisms: Insights From REPRIEVE (ABSTRACT
45)
Markella V. Zanni
Massachusetts General Hospital, Boston, MA, USA
Immunomodulation and Cardiovascular Disease: Lessons Learned From HIV (ABSTRACT
46)
Priscilla Y. Hsue
University of California San Francisco, San Francisco, CA, USA
Implications for Implementing CVD Risk Prevention Strategies for Low- and Middle-Income Countries (ABSTRACT
47)
Mpiko Ntsekhe
University of Cape Town, Cape Town, South Africa
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
5 of
5
|
